Finalized November 4, 2026 | Effective January 1, 2027
It's that time of year again! CMS has finalized the 2027 Medicare Physician Fee Schedule (MPFS), and there are several dermatology billing changes practices will want on their radar.
From lower conversion factors to changes in same-day E/M and procedure payments, the new rule brings a few important updates that could affect reimbursement, billing workflows, and the bottom line. Here's a closer look at what's changing and what your practice can do to prepare.
Starting January 1, 2027, the national conversion factors will decrease:
Why it matters: A lower conversion factor means less reimbursement, but the impact won't be the same for every service. RVU changes and other payment adjustments also play a role.
CMS finalized a payment reduction when a separately identifiable office/outpatient E/M visit is billed on the same day as a 0-day global procedure by the same physician or practitioner within the same practice.
Under the finalized policy, the higher-priced service is paid at 100%, while the lower-priced service is paid at 80%. The policy does not extend to 10- or 90-day global procedures.
Why it matters: Modifier 25 identifies a significant, separately identifiable evaluation and management (E/M) service performed by the same physician or other qualified healthcare professional on the same date as another service or procedure. It does not automatically justify separate payment: documentation must support E/M work above and beyond the usual care associated with the procedure. It's time to review those workflows, understand where the new payment reduction applies, and make sure billing teams know what to expect.
CMS finalized a transition from separate reporting of HCPCS G2211 to modifier B1, which increases payment for the associated E/M code by 16%.
Why it matters: This isn't a change to overlook during system updates. Practices and RCM teams should confirm the implementation requirements, update billing workflows, and make sure staff understand how the new modifier will be used.
CMS is revising how indirect practice expenses are allocated and phasing out the historical indirect practice cost index over two years, using a new stabilizing approach.
Why it matters: These changes could shift reimbursement across specialties and individual services. Don't assume every dermatology code will experience the same impact. A closer look at high-volume CPT codes will help practices understand where payment may change.
Understanding the rule is one thing; preparing for it is another. Here are five practical steps to put on your to-do list.
The CMS 2027 MPFS Final Rule brings several changes that deserve a place on every dermatology practice's planning list. Lower conversion factors, reduced payment for certain same-day E/M and procedure combinations, changes to E/M complexity reporting, and revised practice expense calculations could all affect dermatology Medicare reimbursement.
The best approach? Prepare now rather than troubleshoot later. Review your highest-volume services, communicate changes to the people who handle billing, and monitor the results once the new rules take effect.
A little preparation now can go a long way toward making the transition smoother for your practice and your RCM team.
More from Ezderm:
As always, review the final rule and applicable CMS billing guidance for the specific requirements that apply to your practice.